Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial

British Journal of Psychiatry

Volumn 176, Issue APR., 2000, Pages 363-368

  Michelson, David ^a   Fava, Maurizio ^b   Amsterdam, Jay ^c   Apter, Jeffrey ^d   Londborg, Peter ^e   Tamura, Roy ^a   Tepner, Rosalinda G ^a  

^a ELI LILLY AND COMPANY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Princeton Biomedical Research   (United States)

^e Seattle Biomedical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; ANALYSIS OF VARIANCE; MENTAL DISEASE; RISK FACTOR; WITHDRAWAL SYNDROME;

ADULT; ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MENTAL DISORDERS; PAROXETINE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0034167383     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.176.4.363     Document Type: Article

References (18)

1. Amsterdam, J D., Fawcett, J., Quitkin, F. M., et al (1997) Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. American Journal of Psychiatry, 154, 963-969.
2. Demyttenaere, K. (1997) Compliance during treatment with antidepressants. Journal of Affective Disorders, 43, 27-39.
3. Fava, M., Rosenbaum, J., Hoog, S. L., et al (1998) A comparison of symptoms following treatment interruption: evidence from a randomized, double-blind trial with fluoxetine, sertraline, and paroxetine. European Psychiatry, 13 (suppl. 4), 204.
4. 1A receptor agonist, in treatment-resistant depression. International Clinical Psychopharmacology, 8, 167-172.
5. Hamilton, M. A. (1967) Development of rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
6. Hodges, J. L. & Lehmann E. I. (1963) Estimates of location based on rank tests. The Annals of Mathematical Statistics, 34, 598-611.
7. Kilpatrick, G. J., Bunca, K. T. & Tyars, M. B. (1990) 5-HT3 receptors. Medicinal Research Reviews, 10, 441-475.
8. Nielson, O. A., Morsing, I., Petersen, J. S., et al (1991) Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements. Acta Psychiatrica Scandinavica, 84, 233-241.
9. Noyes, R. Jr, Garvey, M. J., Cook, B., et al (1991) Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry, 148, 517-523.
10. Prescott, R. J. (1981) The comparison of success rates in cross-over trials in the presence of an order effect. Applied Statistics, 30, 9-15.
11. Price, J. S., Waller, P. C., Wood, S. M., et al (1996) A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. British Journal of Clinical Pharmacology, 42, 757-763.
12. Richelson, E. (1996) Synaptic effects of antidepressants. Journal of Clinical Psychopharmacology, 16 (suppl. 2), 1-7.
13. _ (1998) Serotonin: and what about its side effects? Depression and Anxiety, 7 (suppl. 1), 18-20.
14. Rickels, K., Fox, I. L., Greenblatt, D. J., et al (1988) Clorazepate and lorazepam: clinical improvement and rebound anxiety. American Journal of Psychiatry, 145, 312-317.
15. Rosenbaum, J. F., Fava, M., Hoog, S. L., et al (1998) Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biological Psychiatry, 44, 77-87.
16. Schweiser, E., Rickels, K., Case, W. G., et al (1990) Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. Archives of General Psychiatry, 47, 908-915.
17. Spielberger, C. D. (1983) Manual for the State Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists.
18. Zajecka, J., Fawcett, J., Amsterdam, J., et al (1998) Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. Journal of Clinical Psychopharmacology, 18, 193-197.